A trio of bipartisan lawmakers reintroduced a bill requiring the FTC and Treasury to investigate whether the U.S. relies too ...

CMS wants to build a standardized payment structure for clinical software and AI that factors in their impact on patient ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

Some of the most powerful medicines we will ever find are already here, carried in the fangs, stingers, and saliva of ...

This is the year artificial intelligence has emerged in the public square as a full-fledged bogeyman. So this month’s low-key ...

Glenmark Pharmaceuticals agreed to pay $29.6 million to settle price-fixing allegations in a long-running battle with dozens ...

Erica Schwartz and Sean Kaufman navigated tough questions about vaccines, political independence, and pushing back on RFK Jr.

An Alzheimer’s drug from Biogen slowed cognitive decline in a mid-stage trial at roughly comparable rates as approved ...

A new study claims to have uncovered how Epstein-Barr virus launches immune responses seen in people with multiple sclerosis.

Managing risk factors is the key to further progress in reducing deaths from coronary artery disease, a new study finds.

Medicare regulators on Tuesday proposed to ban vendors from providing remote patient monitoring services on behalf of doctors ...

When the body’s most important blood vessel tears from the inside, it’s a medical emergency that can be years in the making.